ÂÜÀòÂÒÂ×

Kathy Tygum Goldstein currently serves as the Executive Director, Head of Global Development Quality at Regeneron Pharmaceuticals, Inc. They previously held positions at Alexion Pharmaceuticals, Inc. as Sr. Director of Quality Operations and at Amarex Clinical Research as Associate Director of Clinical Operations. Kathy has extensive experience in clinical operations and quality management, having worked in various roles including Manager of Clinical Trials at Regeneron Pharmaceuticals and Sr. Clinical Research Associate at Zambon. They are pursuing a BS in Pharmacy from the University of Minnesota and a PharmD from the University of Florida, where they graduated Magna Cum Laude.